Tissue Product Jurisdiction One Focus Of Intercenter Agreement Talks

Tissue-engineered products have been the focus of early discussions related to updating FDA's intercenter agreement on jurisdiction of device-related products, according to agency staff.

More from Archive

More from Medtech Insight